Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Surgery Partners (SGRY) Equity Income (2016 - 2025)

Surgery Partners' Equity Income history spans 11 years, with the latest figure at $6.6 million for Q4 2025.

  • For Q4 2025, Equity Income fell 8.33% year-over-year to $6.6 million; the TTM value through Dec 2025 reached $22.9 million, up 17.44%, while the annual FY2025 figure was $22.9 million, 17.44% up from the prior year.
  • Equity Income for Q4 2025 was $6.6 million at Surgery Partners, up from $5.2 million in the prior quarter.
  • Across five years, Equity Income topped out at $7.2 million in Q4 2024 and bottomed at $2.4 million in Q3 2022.
  • The 5-year median for Equity Income is $3.4 million (2023), against an average of $4.0 million.
  • The largest annual shift saw Equity Income fell 18.18% in 2024 before it surged 107.41% in 2025.
  • A 5-year view of Equity Income shows it stood at $2.8 million in 2021, then soared by 57.14% to $4.4 million in 2022, then grew by 9.09% to $4.8 million in 2023, then soared by 50.0% to $7.2 million in 2024, then decreased by 8.33% to $6.6 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Equity Income are $6.6 million (Q4 2025), $5.2 million (Q3 2025), and $5.5 million (Q2 2025).